Imvaggis is indicated for the local treatment of vaginal symptoms of oestrogen deficiency in postmenopausal women¹¹

• An ultra-low dose, estriol pessary that is easily inserted without the need for an applicator, designed with the patient in mind^{11, 12}
• Imvaggis significantly improves the symptoms of vaginal atrophy vs placebo at 12 weeks (p<0.001)¹³
• The estriol (active ingredient) in Imvaggis is body identical, it is derived from yams and soya and is chemically identical to estriol produced naturally by the body ^{2, 11, 14}
• Imvaggis aligns with recommendations to use the lowest effective dose for treatment of vaginal atrophy¹⁵
• Imvaggis is very well tolerated¹³